Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TITAN PHARMACEUTICALS INC Director's Dealing 2003

Dec 1, 2003

35418_dirs_2003-12-01_f336144f-b4c8-472f-b860-71e4cb297ed4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTP)
CIK: 0000910267
Period of Report: 2003-11-26

Reporting Person: WEIS KONRAD M PHD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-11-26 Common Stock M 5117 $.586 Acquired 35574 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-11-26 Common Stock $.586 M 5117 Acquired 2004-01-05 Common Stock (5117) Direct

Footnotes

F1: N/A